Low-dose radiation exposure and protection against atherosclerosis in ApoE-/- mice: The influence of P53 heterozygosity

Radiation Research

Volumn 179, Issue 2, 2013, Pages 190-199

  Mitchel, R E J ^a   Hasu, M ^b,c   Bugden, M ^a   Wyatt, H ^a   Hildebrandt, G ^d   Chen, Y X ^c   Priest, N D ^a   Whitman, S C ^b,c  

^a ATOMIC ENERGY OF CANADA LIMITED   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GAMMA RADIATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; LOW ENERGY RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MICE; RADIATION DOSAGE; RADIATION INJURIES, EXPERIMENTAL; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874041177     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3140.1     Document Type: Article

References (46)

1. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res 1999; 152:374-89.
2. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 2004; 161:622-32.
3. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160:381-407.
4. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoEdeficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14:133-40.
5. Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Groot PH, et al. Bone marrow transplantation in apolipoprotein Edeficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:3117-26.
6. Mitchel REJ, Hasu M, Bugden M, Wyatt H, Little M, Gola A, et al. Low dose radiation exposure and atherosclerosis in ApoE-/-mice. Radiat Res 2011; 175: 665-76.
7. Sanz-González SM, Barqu?́n L, Garc?́a-Cao I, Roque M, González JM, Fuster JJ, et al. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis. Cardiovascular Res 2007; 75:803-12.
8. Guevara NV, Kim HS, Antonova EI, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 1999; 5:335-9.
9. van Vlijmen BJ, Gerritsen G, Franken AL, Boesten LS, Kockx MM, Gijbels MJ, et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res 2001; 88:780-6.
10. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 2005; 96:667-74.
11. Merched AJ, Williams E, Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodelling. Arterioscler Thromb Vasc Biol 2003; 23:1608-14.
12. Takahashi A. Pre-irradiation at a low dose-rate blunted p53 response. J Radiat Res (Tokyo) 2002; 43:1-9.
13. Wang X, Matsumoto H, Takahashi A, Nakano T, Okaichi K, Ihara M, et al. P53 accumulation in the organs of low-dose X-rayirradiated mice. Cancer Lett 1996; 104:79-84.
14. Wang X, Matsumoto H, Okaichi K, Ohnishi T. P53 accumulation in various organs of rats after whole-body exposure to low-dose Xray irradiation. Anticancer Res 1996; 16:1671-4.
15. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106:927-32.
16. Mercer J, Mahmoudi M, Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat Res 2007; 621:75-86.
17. Andreassi MG. DNA damage, vascular senescence and atherosclerosis. J Mol Med 2008; 86:1033-43.
18. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 2001; 947:271-92.
19. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63:6643-50.
20. Grochola LF, Zeron-Medina J, Mériaux S, Bond GL. Singlenucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol 2010; 2:a001032.
21. Carlisle SM, Burchart P, Mitchel REJ. Cancer and non-cancer risks of early death in normal and cancer-prone Trp53 heterozygous mice exposed to high doses. Radiat Res 2010; 173:40-8.
22. Mitchel REJ, Burchart, Wyatt H. A lower dose threshold for the in vivo protective adaptive response to radiation. Tumorigenesis in chronically exposed normal and Trp53 heterozygous C57BL/6 mice. Radiat Res 2008; 170:765-75.
23. Mitchel REJ. Cancer and low dose responses in vivo: implications for radiation protection. Dose-Response 2007; 5:284-91.
24. Mitchel REJ, Burchart P, Wyatt H. Fractionated, low dose-rate ionizing radiation exposure and chronic ulcerative dermatitis in normal and Trp53 heterozygous C57BL/6 mice. Radiat Res 2007; 168:716-24.
25. Mitchel REJ. Radiation risk prediction and genetics: the influence of the Tp53 gene in vivo. Dose-Response 2005; 3:519-32.
26. Mitchel REJ, Jackson JS, Carlisle SM. Upper dose thresholds for radiation-induced adaptive response against cancer in high-doseexposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 2004; 162:20-30.
27. Mitchel REJ, Dolling J-A, Misonoh J, Boreham DR. Influence of prior exposure to low-dose adapting radiation on radiation-induced teratogenic effects in fetal mice with varying Trp53 function. Radiat Res 2002; 158:458-63.
28. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990; 11(Suppl. E):3-19.
29. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol 1992; 421:277-90.
30. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol 2003; 209:293-309.
31. Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/-mice. J Interferon Cytokine Res 2002; 22:661-70.
32. Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E-/-mice through release of interferon-gamma. Circ Res 2002; 90:E34-E38.
33. Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/-mice. Am J Pathol 2000; 157:1819-24.
34. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull Jr. W, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89:2462-78.
35. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull Jr. W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92:1355-74.
36. Whitman SC. A practical approach to using mice in atherosclerosis research. Clin Biochem Rev 2004; 25:81-93.
37. Howe GR, Zablotska LB, Fix JJ, Egel J, Buchanan J. Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat Res 2004; 162:517-26.
38. Yamada M, Naito K, Kasagi F, Masunari N, Suzuki G. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study. Int J Radiat Biol 2005; 81:821-6.
39. McGale P, Darby SC. Low doses of ionizing radiation and circulatory diseases: A systematic review of the published epidemiological evidence. Radiat Res 2005; 163:247-57.
40. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010; 340:b5349.
41. Grosche B, Lackland DT, Land CE, Simon SL, Apsalikov KN, Bauer S, et al. Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960-1999, and its relationship to radiation exposure. Radiat Res 2011; 176:660-9.
42. Sponsler R, Cameron JR. Nuclear shipyard worker study (1980-1988): A large cohort exposed to low-dose-rate gamma radiation. Int J Low Radiat 2005; 1:463-78.
43. Vrijheid M, Cardis E, Ashmore P, Auvinen A, Bae JM, Engels H, et al. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-country study of nuclear industry workers. Int J Epidemiol 2007; 36:1126-35.
44. Mitchel REJ, Jackson JS, McCann RA, Boreham DR. Adaptive response modification of latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat Res 1999; 152:273-9.
45. Mitchel REJ, Jackson JS, Morrison DP, Carlisle SM. Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer prone, radiation sensitive Trp53 heterozygous mice, Radiat Res 2003; 159:320-7.
46. Mitchel REJ. The dose window for radiation-induced protective adaptive responses. Dose-Response 2010; 8:192-208.